Literature DB >> 16419106

Molecular epidemiology of hepatitis B virus in Dakar, Sénégal.

Muriel Vray1, Jean-Marc Debonne, Jean-Marie Sire, Nathalie Tran, Benoit Chevalier, Jean-Christophe Plantier, Fatou Fall, Guy Vernet, François Simon, Papa Saliou Mb.   

Abstract

Using DNA chip technology and real-time quantitative PCR, molecular profile of HBV strains infecting blood donors and patients in Dakar, Sénégal was studied. All HBsAg-positive blood donors (n = 175) and all patients who presented with chronic hepatitis B (n = 29) between 1st June 2003 and 31st July 2003 were studied. One patient, a blood donor, was coinfected by HCV, and nine patients had anti-HDV antibodies. Few persons in either group were HBeAg-positive. Viral load values were relatively low but correlated with biochemical abnormalities. Patients were infected mainly by genotype E (72%). Patients infected by genotype A (28%) tended to be younger than other patients. There was no significant difference between the blood donors and the patients with hepatitis B as regards virological markers, including viral load, when the HBV genotype was taken into account. The BCP A1762T and G1764A mutations were found in four patients and one patient, respectively; the two mutations were never found in the same patient. The W28* mutation at position 1896 of the core was detected in 19 of the 32 genotyped patients, 18 (83%) of whom had genotype E infection. ALT levels were not influenced by HBV mutations. This study shows a low frequency of clinical signs in HBsAg-positive blood donors, a relatively low level of viral replication, and a high frequency of pre-core mutants in this West African population. These results underline the importance of molecular characterization of HBV infection as specific treatments become available in this region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16419106     DOI: 10.1002/jmv.20544

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

1.  Origin and evolutionary dynamics of Hepatitis B virus (HBV) genotype E in Madagascar.

Authors:  Alessandra Lo Presti; Soa Fy Andriamandimby; Alessia Lai; Silvia Angeletti; Eleonora Cella; Giovanni Mottini; Michele Pier Luca Guarino; Claudia Balotta; Massimo Galli; Jean-Michel Heraud; Gianguglielmo Zehender; Massimo Ciccozzi
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

2.  Prevention and Care of Hepatitis B in Senegal; Awareness and Attitudes of Medical Practitioners.

Authors:  Antoine Jaquet; Gilles Wandeler; Judicaël Tine; Mouhamadou Baïla Diallo; Noel M Manga; Ndeye Mery Dia; Fatou Fall; François Dabis; Moussa Seydi
Journal:  Am J Trop Med Hyg       Date:  2017-08       Impact factor: 2.345

3.  Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.

Authors:  Jennifer Grant; Oche Agbaji; Anna Kramvis; Mukhlid Yousif; Mu'azu Auwal; Sudhir Penugonda; Placid Ugoagwu; Robert Murphy; Claudia Hawkins
Journal:  Trop Med Int Health       Date:  2017-05-22       Impact factor: 2.622

4.  Microarray for hepatitis B virus genotyping and detection of 994 mutations along the genome.

Authors:  Marie Gauthier; Bertrand Bonnaud; Maud Arsac; Fabien Lavocat; Jérôme Maisetti; Alan Kay; François Simon; Fabien Zoulim; Guy Vernet
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

5.  Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).

Authors:  Lauren Périères; Aldiouma Diallo; Fabienne Marcellin; Marie Libérée Nishimwe; El Hadji Ba; Marion Coste; Gora Lo; Philippe Halfon; Coumba Touré Kane; Gwenaëlle Maradan; Patrizia Carrieri; Assane Diouf; Yusuke Shimakawa; Cheikh Sokhna; Sylvie Boyer
Journal:  Hepatol Commun       Date:  2021-12-17

6.  Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies.

Authors:  Antoine Jaquet; Marcellin Nouaman; Judicaël Tine; Aristophane Tanon; Camille Anoma; André Inwoley; Alain Attia; Didier K Ekouevi; Moussa Seydi; François Dabis; Gilles Wandeler
Journal:  Liver Int       Date:  2017-06-22       Impact factor: 5.828

7.  Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa.

Authors:  Abdoulaye Seck; Fatou Ndiaye; Sarah Maylin; Babacar Ndiaye; François Simon; Anna L Funk; Arnaud Fontanet; Kazuaki Takahashi; Sheikh Mohammad Fazle Akbar; Shunji Mishiro; Raymond Bercion; Muriel Vray; Yusuke Shimakawa
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

8.  Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.

Authors:  Papa Saliou Mbaye; Anna Sarr; Jean-Marie Sire; Marie-Louise Evra; Adama Ba; Jean Daveiga; Aboubakry Diallo; Fatou Fall; Loic Chartier; François Simon; Muriel Vray
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

9.  Low immune response to hepatitis B vaccine among children in Dakar, Senegal.

Authors:  Marie-Anne Rey-Cuille; Abdoulaye Seck; Richard Njouom; Loïc Chartier; Housseyn Dembel Sow; Amadou Sidy Ka; Mohamadou Njankouo; Dominique Rousset; Tamara Giles-Vernick; Guillemette Unal; Jean-Marie Sire; Benoît Garin; François Simon; Muriel Vray
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

10.  Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa.

Authors:  Iris E Andernach; Claudine Nolte; Jean W Pape; Claude P Muller
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.